A partnership between Worthington's Cambridge Technologies, developers of autogenous vaccines in the livestock and poultry industries, and Merck Animal Health, manufacturers of mass-produced vaccines, ...
COVID-19, influenza, and respiratory syncytial virus (RSV) vaccination coverage is low among adults so far this respiratory virus season (2024 to 2025).